Tagrisso 80mg 30 Film Coated Tablets

Active Ingredient: Osimertinib Non-small cell lung cancer, metastatic: First-line treatment of metastatic non-small cell lung cancer (NSCLC) in patients whose tumors have epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R mutations (as detected by an approved test) Treatment of metastatic EGFR T790M mutation-positive (as detected by an approved test) NSCLC in patients whose disease has progressed on or after EGFR tyrosine kinase inhibitor therapy